Symptom clusters are prevalent among patients with thyroid cancer during early survivorship and are significantly associated with poorer quality of life, while female patients and those undergoing total thyroidectomy may be at increased risk for poorer quality of life.
Jie Gao, Xin Wang, Jia-Yan Cao et al.· The Oncologist· 0 citations
Triple-negative breast cancer (TNBC) remains a highly aggressive breast cancer subtype with limited molecularly targeted treatment options, while acevaltrate (ACE), a natural dual-target ferroptosis inducer, is constrained by poor aqueous solubility and insufficient tumor accumulation. Here, we engineered cyclic Arg-...
Background This study addresses the safety profiles and molecular mechanisms of trastuzumab monotherapy and its combination with lapatinib, neratinib, and tucatinib for treating HER2-positive tumors. Methods The research integrates a multi-platform approach, including data from the US Food and Drug Administration Adver...
Xiao Chen, Xiao Han, Yuan-Yuan Zhang et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.